ANXA1 and ischemic stroke: In conclusion, this research investigates a previously unrecognized role of SIRT5 and reveals that targeting SIRT5 and/or its interaction with ANXA1 in microglia might be a promising potential therapeutic strategy for ischaemic stroke and probably other kinds of neurological diseases with neuroinflammatory manifestations.